138 related articles for article (PubMed ID: 2280889)
1. Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons.
French ED; Ceci A
Neurosci Lett; 1990 Nov; 119(2):159-62. PubMed ID: 2280889
[TBL] [Abstract][Full Text] [Related]
2. MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: comparison to competitive NMDA antagonists.
French ED; Mura A; Wang T
Synapse; 1993 Feb; 13(2):108-16. PubMed ID: 8446919
[TBL] [Abstract][Full Text] [Related]
3. Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine.
French ED; Ferkany J; Abreu M; Levenson S
Neuropharmacology; 1991 Oct; 30(10):1039-46. PubMed ID: 1836840
[TBL] [Abstract][Full Text] [Related]
4. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems.
Gronier B; Debonnel G
Eur J Pharmacol; 1999 Mar; 368(2-3):183-96. PubMed ID: 10193654
[TBL] [Abstract][Full Text] [Related]
5. N-methyl-D-aspartic acid biphasically regulates the biochemical and electrophysiological response of A10 dopamine neurons in the ventral tegmental area: in vivo microdialysis and in vitro electrophysiological studies.
Wang T; O'Connor WT; Ungerstedt U; French ED
Brain Res; 1994 Dec; 666(2):255-62. PubMed ID: 7882036
[TBL] [Abstract][Full Text] [Related]
6. Distinct neuroprotective profiles for sigma ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies.
Lockhart BP; Soulard P; Benicourt C; Privat A; Junien JL
Brain Res; 1995 Mar; 675(1-2):110-20. PubMed ID: 7796119
[TBL] [Abstract][Full Text] [Related]
7. Competitive NMDA receptor antagonists attenuate phencyclidine-induced excitations of A10 dopamine neurons.
French ED
Eur J Pharmacol; 1992 Jun; 217(1):1-7. PubMed ID: 1397021
[TBL] [Abstract][Full Text] [Related]
8. Similar behavioural effects of sigma agonists and PCP-like non-competitive NMDA antagonists in guinea-pigs.
Brent PJ
Psychopharmacology (Berl); 1991; 105(3):421-7. PubMed ID: 1686818
[TBL] [Abstract][Full Text] [Related]
9. Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization.
Murase S; Mathé JM; Grenhoff J; Svensson TH
J Neural Transm Gen Sect; 1993; 91(1):13-25. PubMed ID: 8452684
[TBL] [Abstract][Full Text] [Related]
10. Effects of phencyclidine on spontaneous and excitatory amino acid-induced activity of ventral tegmental dopamine neurons: an extracellular in vitro study.
Wang T; French ED
Life Sci; 1993; 53(1):49-56. PubMed ID: 7685848
[TBL] [Abstract][Full Text] [Related]
11. Irreversible receptor inactivation reveals differences in dopamine receptor reserve between A9 and A10 dopamine systems: an electrophysiological analysis.
Cox RF; Waszczak BL
Brain Res; 1990 Nov; 534(1-2):273-82. PubMed ID: 1981482
[TBL] [Abstract][Full Text] [Related]
12. Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (PCP) binding site: tentative evidence for PCP recognition sites not coupled to N-methyl-D-aspartate (NMDA) receptors.
Rao TS; Kim HS; Lehmann J; Martin LL; Wood PL
Neuropharmacology; 1990 Mar; 29(3):225-30. PubMed ID: 2158000
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological effects of selective sigma-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons.
Steinfels GF; Tam SW; Cook L
Neuropsychopharmacology; 1989 Sep; 2(3):201-8. PubMed ID: 2571340
[TBL] [Abstract][Full Text] [Related]
14. Phencyclidine and the midbrain dopamine system: electrophysiology and behavior.
French ED
Neurotoxicol Teratol; 1994; 16(4):355-62. PubMed ID: 7968939
[TBL] [Abstract][Full Text] [Related]
15. Contrasting neurochemical interactions of tiletamine, a potent phencyclidine (PCP) receptor ligand, with the N-methyl-D-aspartate-coupled and -uncoupled PCP recognition sites.
Rao TS; Contreras PC; Cler JA; Mick SJ; Dilworth VM; Iyengar S; Monahan JB; Wood PL
J Neurochem; 1991 Mar; 56(3):890-7. PubMed ID: 1847186
[TBL] [Abstract][Full Text] [Related]
16. Regulation of sigma activity by the amino-terminus of substance P in the mouse spinal cord: involvement of phencyclidine (PCP) sites not linked to N-methyl-D-aspartate (NMDA) activity.
Larson AA; Sun X
Neuropharmacology; 1993 Sep; 32(9):909-17. PubMed ID: 7694172
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by sigma receptor ligand, MS-377, of N-methyl- D-aspartate-induced currents in dopamine neurons of the rat ventral tegmental area.
Yamazaki Y; Ishioka M; Matsubayashi H; Amano T; Sasa M
Psychopharmacology (Berl); 2002 Apr; 161(1):64-9. PubMed ID: 11967632
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons.
Hand TH; Hu XT; Wang RY
Brain Res; 1987 Jul; 415(2):257-69. PubMed ID: 3607497
[TBL] [Abstract][Full Text] [Related]
19. Different modulation of the binding to two phencyclidine (PCP) receptor subtypes: effects of N-methyl-D-aspartate agonists and antagonists.
Itzhak Y
Neurosci Lett; 1989 Oct; 104(3):314-9. PubMed ID: 2573019
[TBL] [Abstract][Full Text] [Related]
20. Effects of phencyclidine on ventral tegmental A10 dopamine neurons in the rat.
French ED
Neuropharmacology; 1986 Mar; 25(3):241-8. PubMed ID: 3703174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
